Presenter: Alena Guggenheim, ND

Original Date: February 11, 2017

Autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus are common, debilitating, and expensive diseases to manage. Current treatment strategies rarely achieve full remission, and the side effects of treatment can be severe. New research is uncovering that the immune system, like any other organ system in the body, has metabolic changes during the disease process. We are now understanding that immune mediated diseases can develop a metabolic signature, and therapies that modulate energy utilization within immune cells is uncovering new and exciting therapies.

1.5 General CEUs approved by OBNM